Usosayensi oyinhloko kaMingCeler

UDkt. Guangming Wu, PhD

UDkt. Guangming Wu, uprofesa we-Guangzhou Bio-land Laboratory, wasebenza njengozakwethu wocwaningo noma omunye owaba ngudokotela e-New England Medical Animal Center, eBrown University, University of Missouri-Columbia, Temple University School of Medicine, kanye nezinye izikhungo zocwaningo ezidumile emhlabeni wonke. .Ngo-2004, wajoyina i-Max Planck Institute for Molecular Biology (MPI) eJalimane, lapho asebenza khona noProf. Hans R. Schöler (Ilungu le-German National Academy of Sciences) ekuthuthukiseni imibungu yegundane kanye nezinqubo ze-stem cell.

UDkt. Wu ubesebenza ngezindlela zamangqamuzana omuntu, ingulube, inkomo, negundane kanye nokuthuthukiswa kombungu wakuqala, kanye nokusungulwa kwe-totipotency kanye ne-pluripotency iminyaka engaphezu kwengu-30, futhi wazi kahle amasiko ahlukahlukene e-embryonic in vitro kanye ne-micro. amasu okukhohlisa.Ungowokuqala futhi okwamanje usosayensi oyedwa ukwandisa izinga lokuzalwa kwamagundane atholakala kubuchwepheshe besinxephezelo se-tetraploid kusuka ku-1-5% kuya ku-30-60% ngokusebenzisa ukulungiswa, ukufeza ukuthuthukiswa kwezimboni kobuchwepheshe.Ubhale ngokuhlanganyela amaphepha e-SCI angama-79 anomthelela ohlangene wezingcaphuno ezingaphezu kuka-670 nezingaphezu kuka-7150 futhi ushicilele kumajenali aphesheya aphezulu njengeNature, Cell stem cell, njll.

Ngomnikelo wakhe oncomekayo ekwenziweni kombungu, igama likaDkt. Wu liboniswa unomphela eMunich's Deutsches Museum, okuyimnyuziyamu yesayensi nobuchwepheshe enkulu kunazo zonke emhlabeni.

Ngo-Agasti 2019, uDkt. Wu wethulwa e-China njengomcwaningi wesikhathi esigcwele, yena nethimba lakhe labacwaningi bakha ngempumelelo imodeli yegundane elenziwe abantu i-ACE2 phakathi kwezinsuku ezingama-35, babeka "isisekelo" sokuhlola socwaningo lwe-COVID-19 pathogenesis, ukuhlolwa kwezidakamizwa, nokuthuthukiswa komgomo.Ngenxa yezimpumelelo zakhe ezinhle kwezesayensi nobuchwepheshe, uDkt. Wu waklonyeliswa ngokuthi "Umuntu Othuthukile Ekulweni ne-COVID-19 esifundazweni sase-Guangdong" ngo-2020.

Ukuthuthukiswa okuyimpumelelo kanye nokusetshenziswa kobuchwepheshe obuthuthuke kakhulu besizukulwane esilandelayo se-Tetraploid Complementation (ubuchwepheshe be-TurboMice™) ekufanekiseni amagundane ngesikhathi sokulwa ne-COVID-19, kukhuthaza uDkt. Wu ukuthi alwele ukubaluleka okukhulu ekuthuthukisweni kwemithi ye-biopharmaceuticals.Ngakho-ke, wasungula i-Guangzhou MingCeler Biotech Co., Ltd njengososayensi oyinhloko, ezibophezela ekuguquleni ubuchwepheshe be-TurboMice™ kusukela elabhorethri kuya ekusetshenzisweni kwezimboni ukuhlinzeka ngemikhiqizo yamagundane esezingeni eliphezulu kanye nezinsizakalo zamanyuvesi omhlaba, izikhungo zocwaningo, izibhedlela, kanye nezinkampani zemithi ezibandakanyeka ocwaningweni lwezempilo lwempilo.